Q3 2018 13F Holders as of 30 Sep 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
27,020,094
-
Share change
-
-426,638
-
Total reported value
-
$175,634,278
-
Put/Call ratio
-
296%
-
Price per share
-
$6.50
-
Number of holders
-
83
-
Value change
-
-$3,136,275
-
Number of buys
-
43
-
Number of sells
-
31
Institutional Holders of JOUNCE THERAPEUTICS INC - COM (JNCE) as of Q3 2018
As of 30 Sep 2018 JOUNCE THERAPEUTICS INC - COM (JNCE) had 83 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 27,020,094 shares of stock of the company.
Largest 10 holders included TRV GP II, LLC, TRV GP III, LLC, FMR LLC, WELLINGTON MANAGEMENT GROUP LLP, BlackRock Inc., Vanguard Group Inc, MILLENNIUM MANAGEMENT LLC, Pharmstandard International S.A., Omega Fund Management, LLC, and JPMORGAN CHASE & CO.
This table shows 83 institutional shareholders of the security as of 30 Sep 2018.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.